The IND: What is it and who needs it?
Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome
An analysis of errors in blood component transfusion records with regard to quality improvement of data acquisition and to the performance of lookback and traceback procedures
Obtaining an accepted Investigational New Drug application to operate an umbilical cord blood bank
A molecular approach for isolating high-affinity Fab fragments that are useful in blood group serology
The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms
IgG titer, subclass, and light-chain phenotype of pregnancy-induced HPA-5b antibodies that cause or do not cause neonatal alloimmune thrombocytopenia
Distinguishing immunosilent AIDS from the acute retroviral syndrome in a frequent blood donor
Transfusion with blood from a donor with chronic myelogenous leukemia: persistence of the bcr/abl translocation in the recipient
Where does preoperative erythropoietin therapy count? A mathematical perspective
The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling
Kinetics of peripheral blood stem cell harvests during a single apheresis
Changes in serum osteocalcin and bone-specific alkaline phosphatase are associated with bone pain in donors receiving granulocyte-colony-stimulating factor for peripheral blood stem and progenitor cell collection
High deferral rate for maternal-neonatal donor pairs for an allogeneic umbilical cord blood bank
Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil-platelet aggregates
Hepatitis G virus in intramuscular and intravenous immunoglobulin products manufactured in Europe
Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels
Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels
Optimal platelet dosing
Optimal platelet dosing